Arsham Sheybani

Medicine & Life Sciences

1. Glaucoma 100%
2. Intraocular Pressure 58%
3. Open Angle Glaucoma 47%
4. Stents 46%
5. Gels 44%
6. Eye 32%
7. Cataract 30%
8. Trabeculectomy 19%
9. Macular Degeneration 16%
10. Phacoemulsification 16%
11. Exfoliation Syndrome 16%
12. Safety 15%
13. Equipment and Supplies 14%
14. Growth Differentiation Factor 15 14%
15. Aqueous Humor 13%
16. Cost of Illness 12%
17. Bevacizumab 12%
18. Glaucoma Drainage Implants 11%
19. AR-13324 11%
20. Ocular Vision 10%
21. Visual Acuity 10%
22. Intraocular Lenses 10%
23. Surgeons 9%
24. Choroidal Neovascularization 8%
25. Paecilomyces 8%
26. Bimatoprost 8%
27. Visual Fields 8%
28. Blister 8%
29. Gelatin 8%
30. Thiazoles 8%
31. Iritis 8%
32. Corneal Edema 8%
33. Fibromuscular Dysplasia 7%
34. Vascular Endothelial Growth Factor A 7%
35. Therapeutics 7%
36. Penicillium 7%
37. Epiretinal Membrane 7%
38. Histoplasmosis 7%
39. Ranibizumab 7%
40. Electroretinography 7%
41. Anterior Chamber 7%
42. Marfan Syndrome 6%
43. Penetrating Keratoplasty 6%
44. Ocular Hypertension 6%
45. Intraocular Lens Implantation 6%
46. Uveitis 6%
47. Oxides 6%
48. Keratitis 6%
49. Retinal Vessels 6%
50. Filtering Surgery 6%